Holcomb, Bryan <br/><br/>
Pancreatic cancer cell genetics and signaling response to treatment correlate with efficacy of gemcitabine-based molecular targeting strategies.  [electronic resource] 

 -  Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract  Feb 2008 
 - 288-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1091-255X 
<br/><br/><label>Standard No.: </label>10.1007/s11605-007-0406-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--drug therapy<br/>Antimetabolites, Antineoplastic--administration & dosage<br/>Antineoplastic Agents--administration & dosage<br/>Blotting, Western<br/>Cell Proliferation--drug effects<br/>Chromones--administration & dosage<br/>Curcumin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Dose-Response Relationship, Drug<br/>Drug Synergism<br/>Drug Therapy, Combination<br/>Electrophoretic Mobility Shift Assay<br/>Enzyme Inhibitors--administration & dosage<br/>Humans<br/>MAP Kinase Signaling System--drug effects<br/>Morpholines--administration & dosage<br/>NF-kappa B--drug effects<br/>Pancreatic Neoplasms--drug therapy<br/>Proto-Oncogene Proteins c-akt--drug effects<br/>Tumor Cells, Cultured<br/>Gemcitabine